Skip to main content

Table 1 Immunofluorescence patterns and titers of AIT test in SLE-CMV, SLE and CMV groups

From: Response to 'Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice'

 

Titer

 

Patterns from AIT test

≤1:20

1:40

1:80

1:160

1:320

1:640

1:1280

≥1:2560

Total

SLE-CMV groupa

         

   Homogeneous

     

2

 

9

11

   Homogeneous + speckled

     

4

 

13

17

   Homogeneous + cytoplasmic

       

1

1

   Homogeneous + diffuse granular

       

4

4

   Homogeneous + speckled + cytoplasmic

       

3

3

   Speckled

      

1

8

9

   Speckled + cytoplasmic

   

1

   

1

2

   Diffuse granular + cytoplasmic

       

1

1

   Diffuse cytoplasmic + speckled

       

3

3

   Diffuse cytoplasmic + diffuse granular

       

2

2

   Total

0

0

0

1

0

6

1

45

53

SLE groupb

         

   Homogeneous

     

1

2

15

18

   Homogeneous + speckled

    

2

 

3

33

38

   Homogeneous + cytoplasmic

       

2

2

   Homogeneous + diffuse granular

      

1

12

13

   Homogeneous + speckled + cytoplasmic

    

2

 

1

4

7

   Speckled

    

5

3

5

34

47

   Speckled + cytoplasmic

    

1

3

3

3

10

   Diffuse granular + cytoplasmic

    

2

 

1

5

8

   Diffuse granular

     

1

5

7

13

   Diffuse cytoplasmic + speckled

       

9

9

   Diffuse cytoplasmic + diffuse granular

     

1

1

 

2

   Diffuse cytoplasmic + nucleolar

     

1

 

2

3

   Total

0

0

0

0

12

10

22

126

170

CMV groupc

         

   MTOC-MT

  

4

4

1

1

1

 

11

   MTOC-MT + IF + speckled

 

1

1

2

  

1

 

5

   Speckled

  

2

     

2

   Negative

4

       

4

   Total

4

1

7

6

1

1

2

0

22

  1. aSLE-CMV group, anti-CMV IgM-positive SLE patients; bSLE group, anti-CMV IgM-negative SLE patients; cCMV group, anti-CMV IgM-positive patients without SLE. The AIT test was performed using an indirect immunofluorescent test kit (IT-AITâ„¢; ImmunoThink Co., Seoul, Republic of Korea). In the CMV group, anti-MTOC-MT-positive patients accounted for 72.7% of the total patients in the CMV group and 88.9% of autoantibody-positive patients, but in the SLE-CMV group, anti-MTOC-MT was not detected at all (P < 0.001). Patients in the SLE-CMV group showed high titers of over 1:640 except for one who received steroid pulse therapy just before the test, but the proportion of patients in the CMV group with a titer over 1:640 was not more than 13.6% (P < 0.001). In addition, most of the autoantibody frequently found in the SLE-CMV group was not found in the CMV group. AIT, autoimmune target; CMV, cytomegalovirus; IF, intermediate filament; MTOC-MT, microtubule organizing center with microtubule; SLE, systemic lupus erythematosus.